SinoCellTech (SHA: 688520) has received regulatory approval in China for finotonlimab, making it the first immuno-oncology ...

Risk factors for secondary skin cancer after blood or marrow transplant include those who had treatment with a monoclonal ...

CORONADO, Calif. — Despite recent advances in the treatment of cutaneous squamous cell carcinoma (SCC), a lack of consensus ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...

Discover how a simple saliva test offers a painless and reliable method for early oral cancer detection, potentially ...

Piper Sandler initiated coverage of Merus (MRUS) with an Overweight rating and $84 price target The firm views the company’s EGFRxLGR5 ...

Aloe vera has anti-inflammatory properties that can help soothe and heal the oesophageal lining damaged by acid reflux. In ...

Skin cancer is a common type of cancer that can occur anywhere on the body Read to find out about the least expected areas ...

Air pollution might be playing an increasing role in causing the disease.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

A dermatologist has sounded an alarm over the overlooked danger of genital skin cancer, which can strike both women and men, ...

The World Health Organisation (WHO) is calling for cigarette-style warnings on alcohol to raise awareness about the link ...